VivoSim Labs (VIVS) Capital Expenditures (2011 - 2026)
VivoSim Labs (VIVS) posted Capital Expenditures of $23000.0 for Q2 2026, up 76.92% on a QoQ basis from $13000.0 in Q3 2024.
Powered by 
Analysis
VivoSim Labs (VIVS) Capital Expenditures (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Capital Expenditures for 15 years, with the latest figure at $23000.0 in Q2 2026.
- On a quarterly basis, Capital Expenditures changed N/A year-over-year to $23000.0 in Q2 2026; TTM through Jun 2026 was $23000.0, a 76.92% increase from a year earlier, with the FY2025 full-year figure at $13000.0, down 69.05% from the prior year.
- Capital Expenditures was $23000.0 for Q2 2026 at VivoSim Labs, up from $13000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $162000.0 in Q1 2023, with the low at $13000.0 in Q3 2024.
- Average Capital Expenditures over 4 years is $58555.6, with a median of $41000.0 recorded in 2022.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures surged 310.34% in 2022, then sank 79.73% in 2023.
- Over 4 years, Capital Expenditures stood at $41000.0 in 2022, then plunged by 34.15% to $27000.0 in 2023, then tumbled by 51.85% to $13000.0 in 2024, then surged by 76.92% to $23000.0 in 2026.
- The last three Capital Expenditures figures came in at $23000.0 (Q2 2026), $13000.0 (Q3 2024), and $27000.0 (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 198.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 23.91 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -42.42 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 31.11 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 9.00 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 2.62 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 125,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -55,941.69 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 23,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 162,000.00 |
| Dec 31, 2022 | 41,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 74,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Dec 31, 2021 | 133,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Jun 30, 2021 | 194,000.00 |
| Mar 31, 2021 | 111,000.00 |
| Dec 31, 2020 | 35,000.00 |
| Mar 31, 2019 | 42,000.00 |
| Dec 31, 2018 | 26,000.00 |
| Sep 30, 2018 | 11,000.00 |
| Mar 31, 2018 | 136,000.00 |
| Dec 31, 2017 | 34,000.00 |
| Sep 30, 2017 | 45,000.00 |